News
Press Releases
December 17, 2008
VLST Corporation and Novo Nordisk announce collaboration agreement to develop therapeutics for autoimmune and inflammatory disorders (Adobe Acrobat Required)
July 2, 2008
VLST Corporation Appoints Internationally Recognized Researcher Paul J. Carter, Ph.D. as Chief Scientific Officer (Adobe Acrobat Required)
February 13, 2008
VLST Corporation Announces Board and Executive Management Appointments (Adobe Acrobat Required)
September 12, 2007
VLST Corp Names Consuelo M. Blosch, M.D., Vice President of Clinical and Regulatory and Dan Allison, Ph.D., Sr. Director of Therapeutic Design (Adobe Acrobat Required)
June 16, 2006
VLST Corp. Raises $55 Million: First Accelerator Company to Complete Series B Financing (Adobe Acrobat Required)
March 3, 2006
VLST Corp. Names Julie M. Eastland as Chief Financial Officer (Adobe Acrobat Required)
January 5, 2006
VLST Corp & Accelerator Corporation Name Martin A. Simonetti President and Chief Executive Officer of VLST (Adobe Acrobat Required)
November 18, 2004
Accelerator Corporation Adds $11.8 Million and Two New Investors (Adobe Acrobat Required)
March 19, 2004
Accelerator Corporation Funds Two Emerging Biotech Companies (Adobe Acrobat Required)
In The News
July 21, 2008
Emerging Drug Developer: VLST,, FierceBiotech
July 2, 2008
VLST Hires Top Seattle Genetics Executive, Seattle Post-Intelligencer
January 9, 2006
Startup VLST nabs top execs, Puget Sound Business Journal
January 6, 2006
Ex-Dendreon exec joins VLST Corp.: Biotech picks Simonetti as new CEO, president, Seattle Post-Intelligencer
May 19, 2004
South Lake Union incubator kicks off first two ventures, Seattle Times
May 17, 2004
In the Money: VLST, Seattle Post-Intelligencer